A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany

NCT02076386 · clinicaltrials.gov ↗

COMPLETED

Status

411

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: Dolutegravir

Sponsor

ViiV Healthcare

Collaborators

[object Object]